MetLife Investment Management’s Inogen INGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $92.5K | Buy |
14,337
+8,914
| +164% | +$59K | ﹤0.01% | 2794 |
|
|
2026
Q1 | $33.5K | Sell |
5,423
-7,276
| -57% | -$44.9K | ﹤0.01% | 2712 |
|
|
2025
Q4 | $85.3K | Buy |
12,699
+5,325
| +72% | +$39.9K | ﹤0.01% | 2657 |
|
|
2025
Q3 | $60.2K | Sell |
7,374
-5,851
| -44% | -$43.8K | ﹤0.01% | 2779 |
|
|
2025
Q2 | $93K | Hold |
13,225
| – | – | ﹤0.01% | 2583 |
|
|
2025
Q1 | $94.3K | Sell |
13,225
-280
| -2% | -$2.64K | ﹤0.01% | 2550 |
|
|
2024
Q4 | $124K | Hold |
13,505
| – | – | ﹤0.01% | 2525 |
|
|
2024
Q3 | $131K | Hold |
13,505
| – | – | ﹤0.01% | 2512 |
|
|
2024
Q2 | $110K | Buy |
13,505
+7,118
| +111% | +$55.1K | ﹤0.01% | 2563 |
|
|
2024
Q1 | $51.5K | Sell |
6,387
-6,079
| -49% | -$43K | ﹤0.01% | 2712 |
|
|
2023
Q4 | $68.4K | Hold |
12,466
| – | – | ﹤0.01% | 2741 |
|
|
2023
Q3 | $65.1K | Hold |
12,466
| – | – | ﹤0.01% | 2786 |
|
|
2023
Q2 | $144K | Hold |
12,466
| – | – | ﹤0.01% | 2468 |
|
|
2023
Q1 | $156K | Hold |
12,466
| – | – | ﹤0.01% | 2364 |
|
|
2022
Q4 | $246K | Hold |
12,466
| – | – | ﹤0.01% | 2122 |
|
|
2022
Q3 | $303K | Buy |
12,466
+1,255
| +11% | +$34.6K | ﹤0.01% | 2016 |
|
|
2022
Q2 | $271K | Hold |
11,211
| – | – | ﹤0.01% | 2095 |
|
|
2022
Q1 | $363K | Buy |
11,211
+4,479
| +67% | +$141K | ﹤0.01% | 1977 |
|
|
2021
Q4 | $229K | Hold |
6,732
| – | – | ﹤0.01% | 1970 |
|
|
2021
Q3 | $290K | Sell |
6,732
-1,691
| -20% | -$104K | ﹤0.01% | 1841 |
|
|
2021
Q2 | $549K | Hold |
8,423
| – | – | ﹤0.01% | 1511 |
|
|
2021
Q1 | $442K | Hold |
8,423
| – | – | ﹤0.01% | 1600 |
|
|
2020
Q4 | $376K | Hold |
8,423
| – | – | ﹤0.01% | 1621 |
|
|
2020
Q3 | $244K | Hold |
8,423
| – | – | ﹤0.01% | 1737 |
|
|
2020
Q2 | $299K | Hold |
8,423
| – | – | ﹤0.01% | 1654 |
|
|
2020
Q1 | $435K | Hold |
8,423
| – | – | 0.01% | 1290 |
|
|
2019
Q4 | $576K | Hold |
8,423
| – | – | 0.01% | 1384 |
|
|
2019
Q3 | $404K | Sell |
8,423
-10,653
| -56% | -$556K | ﹤0.01% | 1537 |
|
|
2019
Q2 | $1.27M | Sell |
19,076
-36,373
| -66% | -$2.77M | 0.01% | 1005 |
|
|
2019
Q1 | $5.29M | Buy |
55,449
+37,108
| +202% | +$4.63M | 0.02% | 850 |
|
|
2018
Q4 | $2.28M | Buy |
18,341
+10,738
| +141% | +$1.77M | 0.03% | 700 |
|
|
2018
Q3 | $1.86M | Sell |
7,603
-434
| -5% | -$100K | 0.02% | 892 |
|
|
2018
Q2 | $1.5M | Hold |
8,037
| – | – | 0.02% | 883 |
|
|
2018
Q1 | $987K | Hold |
8,037
| – | – | 0.01% | 1014 |
|
|
2017
Q4 | $957K | Buy |
+8,037
| New | +$885K | 0.01% | 1049 |
|
Other funds holding INGN
DCM
MetLife Investment Management's INGN Position: Q2 2026 in Review
MetLife Investment Management increased its Inogen (INGN) stake by 164% in Q2 2026, buying an estimated $59K and bringing the position to 14,337 shares worth $92.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2794.
MetLife Investment Management first reported a position in INGN in Q4 2017 and has held it in 35 quarters since. The position peaked at $5.29M in Q1 2019. 129 funds tracked by Wall St. Rank hold INGN as of Q2 2026.
- MetLife Investment Management held 14,337 shares of Inogen worth $92.5K as of Q2 2026.
- MetLife Investment Management bought 8,914 Inogen shares in Q2 2026, an estimated $59K.
- Inogen made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2794 holding.
- MetLife Investment Management first reported a position in Inogen in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Inogen position peaked at $5.29M in Q1 2019.
- 129 funds tracked by Wall St. Rank held Inogen as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.